1 |
Roque Bravo R, Carmo H, Valente MJ, Silva JP, Carvalho F, Bastos ML, Dias da Silva D. 4-Fluoromethamphetamine (4-FMA) induces in vitro hepatotoxicity mediated by CYP2E1, CYP2D6, and CYP3A4 metabolism. Toxicology 2021;463:152988. [PMID: 34655687 DOI: 10.1016/j.tox.2021.152988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
2 |
Giorgetti A, Pascali JP, Fais P, Pelletti G, Gabbin A, Franchetti G, Cecchetto G, Viel G. Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications. Life (Basel) 2021;11:440. [PMID: 34068903 DOI: 10.3390/life11050440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
3 |
Oeri HE. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. J Psychopharmacol 2021;35:512-36. [PMID: 32909493 DOI: 10.1177/0269881120920420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Toennes SW, Schneider D, Pogoda W, Paulke A, Wunder C, Theunissen EL, Kuypers KP, Sousa Fernandes Perna E, Ramaekers JG. Pharmacokinetic properties of 4‐fluoroamphetamine in serum and oral fluid after oral ingestion. Drug Test Anal 2019;11:1028-34. [DOI: 10.1002/dta.2595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
5 |
Kuypers KPC, De Sousa Fernandes Perna EB, Theunissen EL, Toennes SW, Mason NL, Hutten NRPW, Ramaekers JG. A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State. Journal of Psychoactive Drugs 2019;51:225-35. [DOI: 10.1080/02791072.2019.1569286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|